









Mercados
/
Ações
/
nasdaq-a
/

Agilent Technologies Inc

123.390USD

+1.520+1.25%

Fechamento 09/26, 16:00（ET）Cotações atrasadas em 15 min

34.99BValor de mercado

28.68P/L TTM



Agilent Technologies Inc

123.390

+1.520+1.25%

Visão Geral Empresa Serviços Financeiros Análises

Visão Geral

Empresa

Serviços Financeiros

Análises

Mais detalhes de Empresa

Informações da empresa

Código da empresaA

Nome da EmpresaAgilent Technologies Inc

Data de listagemNov 18, 1999

CEOMr. Padraig Mcdonnell

Número de funcionários17900

Tipo de títulosOrdinary Share

Fim do ano fiscalNov 18

Endereço5301 Stevens Creek Blvd

CidadeSANTA CLARA

Bolsa de valoresNYSE Consolidated

PaísUnited States of America

Código postal95051

Telefone14083458886

Sitehttps://www.agilent.com/

Código da empresaA

Data de listagemNov 18, 1999

CEOMr. Padraig Mcdonnell

Executivos da empresa

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Boon Hwee Koh

Non-Executive Independent Chairman of the Board

61.55K

+2.11%

Mr. Rodney Gonsalves

Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller

48.45K

+22.91%

Dr. George A. Scangos, Ph.D.

Independent Director

38.35K

+4.98%

Dr. Daniel K. Podolsky, M.D.

Independent Director

35.68K

Mr. Dow R. Wilson

Independent Director

18.04K

+11.21%

Ms. Mala Anand

Independent Director

14.55K

+14.29%

Dr. Otis W. Brawley, M.D.

Independent Director

10.73K

+32.49%

Dr. Mikael G. Dolsten, M.D., Ph.D.

Independent Director

7.54K

+31.77%

Dr. Simon May

Senior Vice President, President, Diagnostics and Genomics

7.32K

-4.79%

Mr. Padraig Mcdonnell

Chief Executive Officer, Director

6.26K

-24.21%

Ver Mais

Nome

Nome/Posição

Posição

Ações detidas

Variação

Mr. Boon Hwee Koh

Non-Executive Independent Chairman of the Board

61.55K

+2.11%

Mr. Rodney Gonsalves

Interim Chief Financial Officer, Principal Accounting Officer, Vice President, Corporate Controller

48.45K

+22.91%

Dr. George A. Scangos, Ph.D.

Independent Director

38.35K

+4.98%

Dr. Daniel K. Podolsky, M.D.

Independent Director

35.68K

Mr. Dow R. Wilson

Independent Director

18.04K

+11.21%

Ms. Mala Anand

Independent Director

14.55K

+14.29%

Detalhamento da receita

Moeda: USDAtualizado em: dom, 6 de jul

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

FY2018

Por EmpresaUSD

Nome

Receita

Proporção

Non-instrumentation and other

1.12B

67.03%

Instrumentation

550.00M

32.97%

Por RegiãoUSD

Nome

Receita

Proporção

United States

678.00M

40.65%

Asia Pacific

548.00M

32.85%

Europe

442.00M

26.50%

Por Empresa

Por Região

Por EmpresaUSD

Nome

Receita

Proporção

Non-instrumentation and other

1.12B

67.03%

Instrumentation

550.00M

32.97%

Distribuição de ações

Atualizado em: sex, 15 de ago

Investidores

Tipos de investidores

Investidores

Proporção

The Vanguard Group, Inc.

11.95%

BlackRock Institutional Trust Company, N.A.

5.24%

State Street Global Advisors (US)

4.39%

MFS Investment Management

4.30%

Wellington Management Company, LLP

3.16%

Outro

70.96%

Investidores

Proporção

The Vanguard Group, Inc.

11.95%

BlackRock Institutional Trust Company, N.A.

5.24%

State Street Global Advisors (US)

4.39%

MFS Investment Management

4.30%

Wellington Management Company, LLP

3.16%

Outro

70.96%

Tipos de investidores

Investidores

Proporção

Investment Advisor

44.60%

Investment Advisor/Hedge Fund

36.02%

Hedge Fund

3.63%

Pension Fund

1.80%

Insurance Company

1.67%

Bank and Trust

1.58%

Research Firm

1.57%

Sovereign Wealth Fund

1.28%

Family Office

0.44%

Outro

7.41%

Participação acionária institucional

Atualizado em: ter, 1 de jul

Período do relatório

N.º de instituições

Ações detidas

Proporção

Variação

2025Q2

2111

262.65M

92.46%

-3.65M

2025Q1

2174

262.93M

92.55%

-7.77M

2024Q4

2144

261.66M

91.77%

-9.44M

2024Q3

2092

261.54M

91.00%

-12.94M

2024Q2

2065

263.61M

90.36%

-18.36M

2024Q1

2066

270.62M

92.35%

-9.44M

2023Q4

2084

269.59M

92.01%

-3.30M

2023Q3

2017

262.63M

89.76%

-13.56M

2023Q2

2002

268.16M

90.78%

-20.64M

2023Q1

1985

271.86M

91.93%

-13.10M

Ver Mais

Atividade dos acionistas

Nome

Ações detidas

Proporção

Variação

Var. %

Data

The Vanguard Group, Inc.

33.28M

11.72%

+239.78K

+0.73%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

15.37M

5.41%

+39.00K

+0.25%

Mar 31, 2025

State Street Global Advisors (US)

12.61M

4.44%

-104.71K

-0.82%

Mar 31, 2025

MFS Investment Management

10.98M

3.87%

-512.88K

-4.46%

Mar 31, 2025

Wellington Management Company, LLP

8.93M

3.14%

-376.03K

-4.04%

Mar 31, 2025

T. Rowe Price Investment Management, Inc.

7.60M

2.68%

-629.16K

-7.65%

Mar 31, 2025

Geode Capital Management, L.L.C.

7.20M

2.54%

+201.68K

+2.88%

Mar 31, 2025

Generation Investment Management LLP

4.98M

1.75%

+824.24K

+19.82%

Mar 31, 2025

Pictet Asset Management Ltd.

5.34M

1.88%

+128.13K

+2.46%

Mar 31, 2025

State Farm Insurance Companies

4.52M

1.59%

Mar 31, 2025

Ver Mais

ETFs Relacionados

Atualizado em: sáb, 6 de set

Nome

Proporção

Honeytree US Equity ETF

4.06%

First Trust Water ETF

3.75%

Goldman Sachs Future Health Care Equity ETF

3.31%

VanEck Morningstar Wide Moat Growth ETF

2.36%

First Trust Indxx Medical Devices ETF

2.36%

VanEck Morningstar Wide Moat Value ETF

2.35%

Invesco Raymond James SB-1 Equity ETF

2.25%

VanEck Morningstar Wide Moat ETF AUD

2.22%

Argent Mid Cap ETF

2.22%

iShares Health Innovation Active ETF

2.16%

Ver Mais

Honeytree US Equity ETF

Proporção4.06%

First Trust Water ETF

Proporção3.75%

Goldman Sachs Future Health Care Equity ETF

Proporção3.31%

VanEck Morningstar Wide Moat Growth ETF

Proporção2.36%

First Trust Indxx Medical Devices ETF

Proporção2.36%

VanEck Morningstar Wide Moat Value ETF

Proporção2.35%

Invesco Raymond James SB-1 Equity ETF

Proporção2.25%

VanEck Morningstar Wide Moat ETF AUD

Proporção2.22%

Argent Mid Cap ETF

Proporção2.22%

iShares Health Innovation Active ETF

Proporção2.16%

Dividendo

Um total de 1.25B USD foi distribuído em dividendos nos últimos 5 anos.

Data

Dividendo

Data de registro

Data de pagamento

Data ex-dividendo

Nov 20, 2024

A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option

Dec 31, 2024

Jan 22, 2025

Dec 31, 2024

Sep 18, 2024

A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option

Oct 01, 2024

Oct 23, 2024

Oct 01, 2024

May 22, 2024

A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024

Jul 02, 2024

Jul 24, 2024

Jul 02, 2024

Feb 21, 2024

A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024

Apr 02, 2024

Apr 24, 2024

Apr 01, 2024

Nov 16, 2023

A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023

Jan 02, 2024

Jan 24, 2024

Dec 29, 2023

Sep 21, 2023

A.NB Final Cash Dividend of gross USD 0.225 paid on Oct 25, 2023 going ex on Oct 02, 2023 with reinvestment option

Oct 03, 2023

Oct 25, 2023

Oct 02, 2023

May 18, 2023

A.NB Interim Cash Dividend of gross USD 0.225 paid on Jul 26, 2023 going ex on Jun 30, 2023 with reinvestment option

Jul 03, 2023

Jul 26, 2023

Jun 30, 2023

Feb 22, 2023

A.NB Interim Cash Dividend of gross USD 0.225 paid on Apr 26, 2023 going ex on Apr 03, 2023

Apr 04, 2023

Apr 26, 2023

Apr 03, 2023

Nov 16, 2022

A.NB Interim Cash Dividend of gross USD 0.225 paid on Jan 25, 2023 going ex on Dec 30, 2022

Jan 03, 2023

Jan 25, 2023

Dec 30, 2022

Sep 21, 2022

A.NB Final Cash Dividend of gross USD 0.21 paid on Oct 26, 2022 going ex on Oct 03, 2022

Oct 04, 2022

Oct 26, 2022

Oct 03, 2022

Ver Mais

Desdobramento de ações

Data

Tipo

Proporção

Sem dados

Data

Tipo

Proporção

Sem dados

KeyAI

